ALG3 as a prognostic biomarker and mediator of PD-1 blockade resistance in hepatocellular carcinoma

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-05-22
DOI
https://doi.org/10.3389/fimmu.2025.1589153
Citations
2
Primary Topic
Glycosylation and Glycoproteins Research
Type
article
Field-Weighted Citation Impact
1.61

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ALG3 as a prognostic biomarker and mediator of PD-1 blockade resistance in hepatocellular carcinoma

Jay Gong, Chenggui Wang, Zhenwei Han, Fei Song et al.
2 citations
Frontiers in Immunology
Glycosylation and Glycoproteins Research
1.61
article

ALG3 as a prognostic biomarker and mediator of PD-1 blockade resistance in hepatocellular carcinoma

Jay Gong, Chenggui Wang, Zhenwei Han, Fei Song, Tianlun Wang, Zhong Chen, Yu Zhang, Yiming Zhao, Peng Tang, Tianxin Xu, Cheng Gao, Yu Wang, Lirong Zhu, Cheng Ji
article en
2 citations

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 16
Nantong University (CN), Affiliated Hospital of Nantong University (CN), Yancheng Third People's Hospital (CN)
National Natural Science Foundation of China, Nantong University
Openalex Percentile: Top 17%
Glycosylation and Glycoproteins Research
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

ALG3 as a prognostic biomarker and mediator of PD-1 blockade resistance in hepatocellular carcinoma — Jay Gong, Chenggui Wang, et al. · Frontiers in Immunology (2025) | TGRS Research Map | TGRS